RxSight
RXST
RXST
58 hedge funds and large institutions have $121M invested in RxSight in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 53 → 58 (+5)
1.7% more ownership
Funds ownership: 32.97% → 34.68% (+1.7%)
Holders
58
Holding in Top 10
–
Calls
$253K
Puts
$13K
Top Buyers
| 1 | +$8.21M | |
| 2 | +$644K | |
| 3 | +$641K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$606K |
| 5 |
BlackRock
New York
|
+$507K |
Top Sellers
| 1 | -$2.66M | |
| 2 | -$1.63M | |
| 3 | -$1.15M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$196K |
| 5 |
SC
Saturna Capital
Bellingham,
Washington
|
-$173K |